Mumbai has emerged as a significant hub for pharmaceutical production , with several firms specializing in the synthesis of Active Pharmaceutical Ingredients (APIs). Notably, a number of prominent firms are focused on the supply of Finasteride API (CAS No: 98319-26-7), meeting the international dema